Open access

Content tagged with Open access

Displaying 1 - 20 of 287 results found

Found in Document library
EMCDDA-EFSA working arrangement, 2019

12.02.2019
Found in Document library
EMCDDA-ECHA working arrangement, 2019

12.02.2019
Found in Document library
France’s National Action Plan on Addiction 2018-22

08.01.2019
Found in Document library
Increasing potency and price of cannabis in Europe, 2006‐2016

29.12.2018
Found in Document library
EMCDDA-EMA working arrangement, 2018

06.12.2018
Found in Document library
EMCDDA-Europol working arrangement, 2018

06.12.2018
Found in Document library
A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids

03.12.2018
Found in Document library
Rights, Respect, and Recovery - Scottland's Alcohol and Drug Strategy

28.11.2018
Found in Document library
Health and social responses to drug problems in prisons

27.11.2018
Found in Document library
Process evaluation of Norway's National Overdose Strategy 2014-17: How to prevent overdose deaths

22.11.2018
Found in Document library
Scottland's Alcohol Framework 2018 - Preventing Harm

20.11.2018
Found in Document library
Ministry of Health, Greece - Strategic Priorities on Responding to Substance Dependence

01.11.2018
Found in Document library
Romania's Action Plan on Drugs 2018-20

31.10.2018
Found in Document library
Council Decision on cyclopropylfentanyl and methoxyacetylfentanyl

28.09.2018
Found in Document library
HCV policies landscape in Europe, 2018 – EMCDDA commissioned study (contract CT.16.IBS.0156.1.0)

19.09.2018
Found in Document library
EU–ANSA agencies’ engagement in the European Union research knowledge cycle: an overview

04.09.2018
Found in Document library
Portugal's National Plan for the Reduction of Addictive Behaviours and Dependencies 2013–20, Interim evaluation

20.08.2018
Found in Document library
Evaluation of Denmark's heroin prescription scheme 2010-12

01.08.2018
Found in Document library
Evaluation of Norway's action plan for the alcohol and drugs field 2016-20. First status report, baseline analysis 2016

01.08.2018
Found in Document library
Long-term opioid agonist treatment participation after first treatment entry is similar across 4 European regions but lower in non-nationals

17.07.2018

1
2
3
4
5
6
7
8
9
…
next ›

Content tagged with Open access

EMCDDA-EFSA working arrangement, 2019

EMCDDA-ECHA working arrangement, 2019

France’s National Action Plan on Addiction 2018-22

Increasing potency and price of cannabis in Europe, 2006‐2016

EMCDDA-EMA working arrangement, 2018

EMCDDA-Europol working arrangement, 2018

A summary of reviews of evidence on the efficacy and safety of medical use of cannabis and cannabinoids

Rights, Respect, and Recovery - Scottland's Alcohol and Drug Strategy

Health and social responses to drug problems in prisons

Process evaluation of Norway's National Overdose Strategy 2014-17: How to prevent overdose deaths

Scottland's Alcohol Framework 2018 - Preventing Harm

Ministry of Health, Greece - Strategic Priorities on Responding to Substance Dependence

Romania's Action Plan on Drugs 2018-20

Council Decision on cyclopropylfentanyl and methoxyacetylfentanyl

HCV policies landscape in Europe, 2018 – EMCDDA commissioned study (contract CT.16.IBS.0156.1.0)

EU–ANSA agencies’ engagement in the European Union research knowledge cycle: an overview

Portugal's National Plan for the Reduction of Addictive Behaviours and Dependencies 2013–20, Interim evaluation

Evaluation of Denmark's heroin prescription scheme 2010-12

Evaluation of Norway's action plan for the alcohol and drugs field 2016-20. First status report, baseline analysis 2016

Long-term opioid agonist treatment participation after first treatment entry is similar across 4 European regions but lower in non-nationals

About the EMCDDA

Follow us

Contact

Feedback and support